GlobeNewswire: Biotricity Contains the last 10 of 97 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T09:46:36ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/01/20/2161381/0/en/Biotricity-Completes-9-5M-of-Convertible-Promissory-Notes-to-Institutional-and-Retail-Investors.html?f=22&fvtc=4&fvtv=28187Biotricity Completes $9.5M of Convertible Promissory Notes to Institutional and Retail Investors2021-01-20T13:00:00Z<![CDATA[REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of closings pursuant to which it sold an aggregate gross proceeds of $9,557,500 of convertible promissory notes to institutional and retail investors in separate offerings. The convertible notes convert into the Company’s common stock at a conversion price equal to 75% of the volume weighted average price of the common stock for the five trading days prior to the conversion date. Additionally, the Company will issue the investors in the offering cash warrants based on the amount of promissory notes converted by the investors. The Company believes that conversion of these promissory notes will be instrumental in the Company’s path towards a senior market listing.]]>https://www.globenewswire.com/news-release/2021/01/11/2156256/0/en/Biotricity-Announces-New-Solution-for-Personal-Heart-Management-with-Bioheart.html?f=22&fvtc=4&fvtv=28187Biotricity Announces New Solution for Personal Heart Management with Bioheart2021-01-11T13:00:00Z<![CDATA[Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format]]>Bioheart used for fitnessBioheart for FitnessBioheart used for lifestyle managementBioheart for Lifestylehttps://www.globenewswire.com/news-release/2021/01/05/2153446/0/en/Biotricity-Submitted-510-k-U-S-FDA-Filing-for-Biotres.html?f=22&fvtc=4&fvtv=28187Biotricity Submitted 510(k) U.S. FDA Filing for Biotres2021-01-05T13:00:00Z<![CDATA[Biotres is a compact and discreet 3 channel holter solution Biotres is a compact and discreet 3 channel holter solution]]>https://www.globenewswire.com/news-release/2020/12/09/2142152/0/en/Biotricity-to-Present-at-the-13th-Annual-LD-Micro-Main-Event-and-Host-Virtual-One-on-One-Meetings-with-Investors.html?f=22&fvtc=4&fvtv=28187Biotricity to Present at the 13th Annual LD Micro Main Event and Host Virtual One-on-One Meetings with Investors2020-12-09T13:00:00Z<![CDATA[REDWOOD CITY, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that CEO Waqaas Al-Siddiq and CFO John Ayanoglou are scheduled to present to a live audience at the 13th Annual LD Micro Main Event virtual investor conference on December 15th, 2020 at 10:20 am Pacific Time (1:20 pm ET). The online presentation will be webcast live and available for replay at the investor relations section of Biotricity’s website.]]>https://www.globenewswire.com/news-release/2020/12/01/2137405/0/en/Biotricity-Prepares-510-k-FDA-Filing-for-Biotres.html?f=22&fvtc=4&fvtv=28187Biotricity Prepares 510(k) FDA Filing for Biotres2020-12-01T13:00:00Z<![CDATA[Required lab testing complete for Biotres a novel holter patch product Required lab testing complete for Biotres a novel holter patch product]]>https://www.globenewswire.com/news-release/2020/11/17/2128291/0/en/Biotricity-Reports-Results-for-the-Quarter-Ended-September-30-2020.html?f=22&fvtc=4&fvtv=28187Biotricity Reports Results for the Quarter Ended September 30, 20202020-11-17T13:00:00Z<![CDATA[REDWOOD CITY, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, reported results for the three months ended September 30, 2020. During the three months ended September 30, 2020, the Company earned device sales and technology fees totaling $744,585. Expansive growth into new clinics adopting Bioflux resulted in September being the Company’s highest revenue-producing month to date. Full results are available on EDGAR or in the Financial Section of the Company’s website.]]>https://www.globenewswire.com/news-release/2020/11/12/2125533/0/en/Biotricity-Launches-Biocare-Telemed-for-Safe-and-Convenient-Remote-Patient-Care.html?f=22&fvtc=4&fvtv=28187Biotricity Launches Biocare Telemed for Safe and Convenient Remote Patient Care2020-11-12T13:00:00Z<![CDATA[Secure HIPAA compliant technology for at-risk chronic care patients Secure HIPAA compliant technology for at-risk chronic care patients]]>https://www.globenewswire.com/news-release/2020/09/29/2100562/0/en/Biotricity-Accelerates-Shift-to-Remote-Monitoring-with-Bioflux-Direct-Program.html?f=22&fvtc=4&fvtv=28187Biotricity Accelerates Shift to Remote Monitoring with Bioflux® Direct Program2020-09-29T12:00:00Z<![CDATA[New offering assists physicians by delivering Bioflux devices directly to at-risk patients, helping them avoid in-office visits New offering assists physicians by delivering Bioflux devices directly to at-risk patients, helping them avoid in-office visits]]>https://www.globenewswire.com/news-release/2020/09/01/2086852/0/en/Biotricity-Provides-Quarter-Update-and-Announces-Continued-Growth.html?f=22&fvtc=4&fvtv=28187Biotricity Provides Quarter Update and Announces Continued Growth2020-09-01T12:00:00Z<![CDATA[Technology Revenues Surged in the Quarter Ended June 30, 2020 Technology Revenues Surged in the Quarter Ended June 30, 2020 ]]>https://www.globenewswire.com/news-release/2020/08/12/2077066/0/en/Biotricity-Signs-Agreement-with-Telemedicine-Company.html?f=22&fvtc=4&fvtv=28187Biotricity Signs Agreement with Telemedicine Company2020-08-12T12:00:00Z<![CDATA[Biotricity is well positioned to provide an integrated telehealth solution combining remote monitoring and telemedicine Biotricity is well positioned to provide an integrated telehealth solution combining remote monitoring and telemedicine]]>